MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/jhc.s495304

Медицинская библиотека · Journal of hepatocellular carcinoma · 2025

Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant.

Zhang Shenyu, Song Ruipeng, Hou Changlong, Yao Huanzhang, Xu Jun, Zhou Hangcheng, Li Shaopeng, Cai Wei, Fei Yipeng, Meng Fanzheng, Yin Dalong, Wang Jiabei, Zhang Shugeng, Liu Yao, Wang Jizhou, Liu Lianxin

СтатьяПеревод в очереди

Аннотация

PURPOSE: Liver venous deprivation (LVD; simultaneous portal vein embolization and hepatic vein embolization) has been the latest surgical strategy for rapid future liver remnant (FLR) hypertrophy. The aim of this study was to assess the feasibility, safety, and efficacy of simultaneous LVD following hepatic arterial chemoembolization (TACE-LVD) before major hepatectomy for hepatocellular carcinoma (HCC).

PATIENTS AND

METHODS

A retrospective analysis of the outcomes of 23 HCC patients who underwent TACE-LVD at our center between October 2019 and October 2023 was conducted. An assessment of postoperative complications, FLR volume, liver function, and tumor response was performed.

RESULTS

All patients successfully underwent TACE-LVD. No other serious complications occurred except in 1 patient who underwent puncture drainage due to excessive pleural effusion. Following TACE-LVD, transaminase levels peak two days before rapidly decreasing and return to preoperative levels within one week. The ratio of FLR to standardized liver volume increased from 35.9% (interquartile range [IQR], 8.6) to 46.4% (IQR, 8.2), with a mean degree of hypertrophy and kinetic growth rate of 13.2% (IQR, 5.4) and 4.4% (IQR, 1.8) per week, respectively. At the first assessment after TACE-LVD, most patients exhibited sufficient FLR for hepatectomy, except for 4 patients with cirrhosis. The modified response evaluation criteria for solid tumor assessment revealed a disease control rate of 95.7%, with only 1 patient (Barcelona Clinic Liver Cancer stage C) developing intrahepatic disease progression.

CONCLUSION

TACE-LVD seems to be a feasible, safe, and effective strategy for rapid FLR hypertrophy. Moreover, TACE-LVD may be a therapeutic choice if insufficient FLR hypertrophy precludes resection. This strategy warrants further exploration.

Для цитирования: Zhang Shenyu, Song Ruipeng, Hou Changlong, Yao Huanzhang, Xu Jun, Zhou Hangcheng, Li Shaopeng, Cai Wei, Fei Yipeng, Meng Fanzheng, Yin Dalong, Wang Jiabei, Zhang Shugeng, Liu Yao, Wang Jizhou, Liu Lianxin. Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant.. Journal of hepatocellular carcinoma. 2025. DOI: 10.2147/jhc.s495304.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.